Levocetirizine
Back to searchMolecule Structure
Scientific Name
Levocetirizine
Description of the Drug
Levocetirizine is an H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06282
http://www.drugbank.ca/drugs/DB06282
Brand Name(s)
Xyzal
Company Owner(s)
Us Antibiotics Llc, Glenmark Generics Limited, Macleods Pharmaceuticals Ltd, Dr Reddys Laboratories Limited, Chartwell Molecular Holdings Llc, Micro Labs Ltd, Perrigo R And D Co, Micro Labs Ltd India, Hetero Labs Ltd Unit Iii, Synthon Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4914 | ||
| Human Metabolome Database | HMDB0240226 | ||
| DrugBank | DB06282 | ||
| PubChem: Thomson Pharma | 14927596 | ||
| PubChem | 1549000 | 28145931 | |
| Mcule | MCULE-5295925191 | ||
| LINCS | LSM-5412 | ||
| Nikkaji | J1.370.778B | ||
| PDBe | LCR | ||
| BindingDB | 85030 | ||
| EPA CompTox Dashboard | DTXSID60156294 | ||
| DrugCentral | 1566 | ||
| ChemicalBook | CB5712207 | ||
| Guide to Pharmacology | 1214 | ||
| rxnorm | LEVOCETIRIZINE | LEVOCETIRIZINE DIHYDROCHLORIDE | XYZAL |
| ChEBI | 94559 | ||
| ZINC | ZINC000019364230 |
